Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
1994-7-1
|
pubmed:abstractText |
This study compared with placebo the efficacy and tolerability of optimised doses of felodipine 5-20 mg daily, metoprolol 50-200 mg daily and their combination in subjects 60 years or over with isolated systolic hypertension. The study employed a randomised double-blind crossover design with allocation of treatment order within subjects by Latin squares. For each subject, after a single-blind run-in placebo phase, there were four randomised treatment phases each of six weeks duration, with a dose titration step at three weeks if necessary. Twenty-eight subjects entered the randomised phases of the study and twenty-one completed all four phases--13 male, 8 female (ages: median 71, range 59-85 years). At the end of both the felodipine and metoprolol phases systolic and diastolic pressure were reduced at 2 hours postdose compared with the placebo phase (p < 0.001), the blood pressure reduction with felodipine (-40/-20 mmHg) being greater than that with metoprolol (-15/-9 mmHg) (p < 0.01). Immediately predose (12 hours postdose) there was a persisting reduction of supine systolic blood pressure (-17 mmHg) with felodipine (p < 0.001), but there was no significant effect of metoprolol. At both measurement times the two drugs when in combination had an additive effect on blood pressure. There was a 20% increase in reported symptoms during each of the active treatment phases. Four subjects withdrew during the randomised phases because of probable drug-related adverse events and six subjects required dosage reductions during the felodipine or combination phases.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0803-7051
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
82-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8199723-Aged,
pubmed-meshheading:8199723-Aged, 80 and over,
pubmed-meshheading:8199723-Blood Pressure,
pubmed-meshheading:8199723-Double-Blind Method,
pubmed-meshheading:8199723-Drug Combinations,
pubmed-meshheading:8199723-Felodipine,
pubmed-meshheading:8199723-Female,
pubmed-meshheading:8199723-Heart Rate,
pubmed-meshheading:8199723-Hemodynamics,
pubmed-meshheading:8199723-Humans,
pubmed-meshheading:8199723-Hypertension,
pubmed-meshheading:8199723-Male,
pubmed-meshheading:8199723-Metoprolol,
pubmed-meshheading:8199723-Middle Aged,
pubmed-meshheading:8199723-Placebos,
pubmed-meshheading:8199723-Systole
|
pubmed:year |
1994
|
pubmed:articleTitle |
Felodipine, metoprolol and their combination compared with placebo in isolated systolic hypertension in the elderly.
|
pubmed:affiliation |
Department of Clinical Pharmacology, Flinders Medical Centre, Bedford Park, Adelaide, Australia.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|